All Article Listing | RxWiki

Health News

FDA Approves New Diabetes Combo Rx

RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Synjardy® (empagliflozin and metformin hydrochloride) tablets, from Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY), for the treatment of adults with type 2 diabetes (T2D).

Second Approval in New Cholesterol Rx Class

Following the recent approval of a first-in-its-class cholesterol medication, a second treatment in this class received the green light from the FDA.

Second in New Cholesterol Rx Class Approved

The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

Omega-3 Supplements May Not Be Cutting It

Omega-3 pills are among the most popular dietary supplements in the US. But these pills may not be living up to their claims.

Seasons Change — and So Does Your Body

Have you noticed your body changing with the seasons? While you’re likely more prone to allergies in the spring or the flu in the winter, there’s more to it than that. From mood to sleep, here’s how fall and winter may throw you for a loop.

A Heart Rx That Could Help Cancer Patients

Beta blockers are a class of heart medications that treat high blood pressure. But for some patients, they may have other lifesaving benefits.

FDA OKs Fully Mobile Glucose Monitor

SAN DIEGO, Aug. 25, 2015 /PRNewswire/ -- Dexcom, Inc., (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration (FDA) has approved the Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System.

Keep Calm and Meditate On

Meditating has become a popular trend - but why? If you're interested in finding your inner zen, check this out.

New Help for Kids with Rare Blood Disorder

Children with a rare blood disorder may soon get new help in the form of a pill.

Rare Blood Disorder Rx Approved for Kids

The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP).

REFINE